e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Novel cellular mechanisms in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema
J. Callegari, N. Kneidinger, A. Bohla, S. Takenaka, A. Önder Yildirim, M. Königshoff (München, Giessen, Germany)
Source:
Annual Congress 2010 - Novel cellular mechanisms in lung disease
Session:
Novel cellular mechanisms in lung disease
Session type:
E-Communication Session
Number:
5677
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Callegari, N. Kneidinger, A. Bohla, S. Takenaka, A. Önder Yildirim, M. Königshoff (München, Giessen, Germany). Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Eur Respir J 2010; 36: Suppl. 54, 5677
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema
Source: International Congress 2018 – Intercellular communication in tissue remodelling
Year: 2018
Late Breaking Abstract - Antagonizing COVID19-induced GPR4 alleviates lung and kidney injury
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Aerobic exercise reduces asthma phenotype by inhibiting purinergic signaling and lymphatic organs hyperactivation
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Calpain regulates epithelial-mesenchymal transition and its correlation with Akt signaling in pulmonary fibrosis.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Late Breaking Abstract - Role of HIF2a oxygen sensing pathway in bronchial epithelium biology
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Late Breaking Abstract - Role of ß-catenin and Notch signalling in increased airway mucous cell differentiation in asthma
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021
Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Late Breaking Abstract - Vitamin D suppresses LPS-induced ER stress and inflammation via modulation of mir-34a/Sirt1 axis in acute lung injury.
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract: Galectin-3 a key regulator in the development of lung fibrosis
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept